| First Author | Yamashita M | Year | 2021 |
| Journal | Nat Immunol | Volume | 22 |
| Issue | 7 | Pages | 893-903 |
| PubMed ID | 34155405 | Mgi Jnum | J:319672 |
| Mgi Id | MGI:6740265 | Doi | 10.1038/s41590-021-00951-z |
| Citation | Yamashita M, et al. (2021) A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS. Nat Immunol 22(7):893-903 |
| abstractText | In the present study, we report a human-inherited, impaired, adaptive immunity disorder, which predominantly manifested as a B cell differentiation defect, caused by a heterozygous IKZF3 missense variant, resulting in a glycine-to-arginine replacement within the DNA-binding domain of the encoded AIOLOS protein. Using mice that bear the corresponding variant and recapitulate the B and T cell phenotypes, we show that the mutant AIOLOS homodimers and AIOLOS-IKAROS heterodimers did not bind the canonical AIOLOS-IKAROS DNA sequence. In addition, homodimers and heterodimers containing one mutant AIOLOS bound to genomic regions lacking both canonical motifs. However, the removal of the dimerization capacity from mutant AIOLOS restored B cell development. Hence, the adaptive immunity defect is caused by the AIOLOS variant hijacking IKAROS function. Heterodimeric interference is a new mechanism of autosomal dominance that causes inborn errors of immunity by impairing protein function via the mutation of its heterodimeric partner. |
